BioSpace News Archive

Business

Sientra Reports Second Quarter 2020 Financial Results

Sientra, Inc., a diversified medical aesthetics company, announced its financial results for the second quarter ended June 30, 2020.

August 10, 2020
·
14 min read
Business

Arcturus Therapeutics Announces Second Quarter 2020 Financial Results and Provides a Corporate Update

COVID-19 STARR™ mRNA vaccine candidate, ARCT-021 (LUNAR-COV19) has initiated Phase 1/2 clinical study with Duke-NUS Medical School; Dosing anticipated imminently, initial data expected Q4

August 10, 2020
·
10 min read
Business

Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2020 Financial Results

Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today provided a corporate update, and reported financial results for the second quarter and six months ended June 30, 2020.

August 10, 2020
·
10 min read
Business

Cara Therapeutics Reports Second Quarter 2020 Financial Results

Cara Therapeutics, Inc., a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors, announced financial results and operational highlights for the second quarter ended June 30, 2020.

August 10, 2020
·
12 min read
Business

Marrone Bio Innovations, Inc. Reports Second Quarter and First Half 2020 Financial Results

Marrone Bio Innovations, Inc. (NASDAQ: MBII) (“Marrone Bio” or the “Company”), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, has provided its financial results for the second quarter ended June 30, 2020.

August 10, 2020
·
16 min read
Business

Halozyme Reports Significant Recent Achievements And Second Quarter 2020 Results

Halozyme Therapeutics, Inc. (NASDAQ: HALO) today reported financial results for the second quarter ended June 30, 2020 and provided an update on its recent corporate activities and outlook.

August 10, 2020
·
12 min read
Business

AGC Biologics Expands Partnership with Novavax

AGC Biologics, a global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced it has expanded its partnership with Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases.

August 10, 2020
·
3 min read
Business

Avidity Biosciences Reports Second Quarter 2020 Financial Results and Recent Highlights

Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company pioneering a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOCs™), today reported financial results for the quarter and six months ended June 30, 2020 and highlighted recent corporate progress.

August 10, 2020
·
7 min read
Business

INOVIO Reports Second Quarter 2020 Financial Results; Provides DNA Medicines Clinical Program Mid-Year Update

INOVIO (NASDAQ:INO), a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, today reported financial results for the quarter ended June 30, 2020.

August 10, 2020
·
24 min read
Business

Castle Biosciences Announces Second Quarter 2020 Results

Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, today announced its financial results for the second quarter and six months ended June 30, 2020

August 10, 2020
·
22 min read